Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882095-25-000047
Filing Date
2025-11-07
Accepted
2025-11-07 16:08:32
Documents
85
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gild-20250930.htm   iXBRL 10-Q 2518215
2 SEVERANCE PLAN (AMENDED AND RESTATED) gildq32025ex1037severancep.htm EX-10.37 257499
3 CEO CERTIFICATION gildq32025ex311ceocertific.htm EX-31.1 8068
4 CFO CERTIFICATION gildq32025ex312cfocertific.htm EX-31.2 7609
5 SECTION 906 CERTIFICATIONS gildq32025ex32section906ce.htm EX-32 5872
  Complete submission text file 0000882095-25-000047.txt   11973133

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20250930.xsd EX-101.SCH 62085
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20250930_cal.xml EX-101.CAL 104702
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20250930_def.xml EX-101.DEF 304650
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20250930_lab.xml EX-101.LAB 750468
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20250930_pre.xml EX-101.PRE 527627
88 EXTRACTED XBRL INSTANCE DOCUMENT gild-20250930_htm.xml XML 2392921
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 251462709
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)